RISK OF CHD IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
多囊卵巢综合症女性患冠心病的风险
基本信息
- 批准号:6641255
- 负责人:
- 金额:$ 50.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-30 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:angiocardioultrasonography atherosclerosis blood coagulation blood pressure body composition cardiovascular disorder epidemiology carotid artery clinical research computed axial tomography coronary disorder coronary vessels disease /disorder proneness /risk female high density lipoproteins human subject insulin longitudinal human study low density lipoprotein mass screening pathologic process photon absorptiometry polycystic ovary syndrome triglycerides vascular endothelium vascular resistance
项目摘要
DESCRIPTION: (Adapted from the Investigator's Abstract) Polycystic ovary
syndrome (PCOS), characterized by chronic anovulation, hyperandrogenism, and
insulin resistance, is estimated to affect four percent to eight percent of all
women. In 1992, the investigators initiated the first large-scale study of
cardiovascular risk factors in women with PCOS (1992-1994). They recruited 244
women with PCOS and 244 age-, race- and neighborhood-matched controls age
(19-50 years of age) and determined that PCOS cases had a profile that
conferred increased cardiovascular risk (increased LDLc, triglycerides, and
waist/hip ratio, obesity, decreased HDLc, hyperinsulinemia, and increased
diastolic and systolic blood pressure). During phase II, (1996-99) they
investigated the prevalence of subclinical atherosclerosis (SCA) of the carotid
arteries in women 30+ years of age from the original cohort. In preliminary
analyses, PCOS cases 45+ years had significantly higher mean intima-media wall
thickness (IMT) than controls (0.75mm vs. 0.70mm, p<.02). The investigators
state that this well established cohort provides a unique opportunity to extend
their study of CHD risk in women with PCOS by conducting more powerful
longitudinal studies of SCA. The specific aims of the present study are to 1)
recruit and screen 160 PCOS cases and 160 controls >=40 years from the original
cohort to determine if PCOS cases have greater initial coronary or aortic
calcification and/or greater progression during years 4 and 5, 2) evaluate the
progression of carotid atherosclerosis over a 5-year period of PCOS cases and
controls >=40 years who participated in Phase II of the study, 3) evaluate
whether CHD risk factors can be linked to the extent of coronary and aortic
calcification within cases and controls, 4) evaluate vascular stiffness in PCOS
cases and controls and determine CHD risk factors for aortic stiffness, and 5)
evaluate endothelial function in PCOS cases and controls and changes over five
years. CHD risk factors will include: HDLt, LDLc, triglycerides, glucose,
insulin, Lp(a), PAI-1, blood pressure, and anthropometric measures. Information
will be obtained on medical, reproductive and physical activity history. The
investigators state that this study has the potential to identify the
determinants of early SCA in this high-risk group of women and has important
implications for primary as well as secondary prevention.
描述:(改编自研究者摘要)多囊卵巢
多囊卵巢综合征(PCOS),以慢性无排卵、高雄激素血症和
据估计,胰岛素抵抗影响了4%到8%的
妇女1992年,研究人员开始了第一次大规模的研究,
多囊卵巢综合征妇女的心血管危险因素(1992-1994)。他们招募了244人
PCOS妇女和244名年龄、种族和邻居匹配的对照者
(19-50岁),并确定PCOS病例的特征,
心血管风险增加(LDL c、甘油三酯和
腰臀比、肥胖、HDL c降低、高胰岛素血症和
舒张压和收缩压)。在第二阶段(1996- 1999年),
调查了颈动脉亚临床动脉粥样硬化(SCA)的患病率
来自原始队列的30岁以上女性的动脉。初步
分析显示,45岁以上的多囊卵巢综合征患者的平均内膜中层壁明显较高
与对照组相比(0.75mm vs.0.70mm,p<0.02)。调查人员
声明,这一成熟的队列提供了一个独特的机会,
他们通过进行更有力的研究,
SCA的纵向研究。本研究的具体目标是:1)
招募和筛选160例PCOS病例和160例对照,年龄>=40岁
队列,以确定PCOS病例是否具有更大的初始冠状动脉或主动脉
钙化和/或更大的进展,2)评估
PCOS患者5年内颈动脉粥样硬化的进展,
对照组>=40岁,参加了研究的第二阶段,3)评估
冠心病危险因素是否与冠状动脉和主动脉病变程度有关
病例组和对照组的钙化情况,4)评估PCOS患者的血管硬度
病例和对照组,并确定主动脉僵硬的CHD危险因素,以及5)
评估PCOS患者和对照者的内皮功能,
年CHD风险因素包括:HDLt、LDLc、甘油三酯、葡萄糖,
胰岛素、Lp(a)、派-1、血压和人体测量。信息
将根据病史、生殖史和体力活动史获得。的
研究人员指出,这项研究有可能确定
早期SCA的决定因素在这个高风险的妇女群体,并具有重要的
对初级和二级预防的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Evelyn O. Talbott其他文献
Birth Weight as a Risk Factor for Breast Cancer: a Meta-Analysis of 18 Epidemiologic Studies
出生体重作为乳腺癌的危险因素:18 项流行病学研究的荟萃分析
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
Xiaohui Xu;Amy B. Dailey;M. Peoples;Evelyn O. Talbott;Ning Li;Jeffrey Roth - 通讯作者:
Jeffrey Roth
Biologic and psychosocial risk factors of sudden death from coronary disease in white women.
白人女性冠心病猝死的生物和心理社会危险因素。
- DOI:
- 发表时间:
1977 - 期刊:
- 影响因子:2.8
- 作者:
Evelyn O. Talbott;L. H. Kuller;K. Detre;J. Perper - 通讯作者:
J. Perper
Risk of longer-term endocrine and metabolic conditions in the Deepwater Horizon Oil Spill Coast Guard cohort study – five years of follow-up
- DOI:
10.1186/s12940-025-01164-9 - 发表时间:
2025-03-22 - 期刊:
- 影响因子:5.900
- 作者:
Hristina Denic-Roberts;Lawrence S. Engel;Jeanine M. Buchanich;Rachel G. Miller;Evelyn O. Talbott;Dana L. Thomas;Jordan McAdam;Jill E. Emerick;Tina Costacou;Jennifer A. Rusiecki - 通讯作者:
Jennifer A. Rusiecki
Evelyn O. Talbott的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Evelyn O. Talbott', 18)}}的其他基金
Identification and Characterization of Potential Environmental Risk Factors for ALS Using the ATSDR ALS Registry Cases and a Control Population
使用 ATSDR ALS 登记案例和对照人群识别和描述 ALS 的潜在环境风险因素
- 批准号:
9475429 - 财政年份:2017
- 资助金额:
$ 50.73万 - 项目类别:
Identification and Characterization of Potential Environmental Risk Factors for ALS Using the ATSDR ALS Registry Cases and a Control Population
使用 ATSDR ALS 登记案例和对照人群识别和描述 ALS 的潜在环境风险因素
- 批准号:
10226784 - 财政年份:2017
- 资助金额:
$ 50.73万 - 项目类别:
CDC Envirnomental Tracking and Disease Surveillance
CDC 环境追踪和疾病监测
- 批准号:
7123759 - 财政年份:2005
- 资助金额:
$ 50.73万 - 项目类别:
CDC Envirnomental Tracking and Disease Surveillance
CDC 环境追踪和疾病监测
- 批准号:
7088671 - 财政年份:2005
- 资助金额:
$ 50.73万 - 项目类别:
CDC Envirnomental Tracking and Disease Surveillance
CDC 环境追踪和疾病监测
- 批准号:
7473783 - 财政年份:2005
- 资助金额:
$ 50.73万 - 项目类别:
CDC Envirnomental Tracking and Disease Surveillance
CDC 环境追踪和疾病监测
- 批准号:
7273643 - 财政年份:2005
- 资助金额:
$ 50.73万 - 项目类别:
CDC Envirnomental Tracking and Disease Surveillance
CDC 环境追踪和疾病监测
- 批准号:
7687596 - 财政年份:2005
- 资助金额:
$ 50.73万 - 项目类别:
Genetics of Insulin Resistance in PCOS: The PPAR Pathway
PCOS 胰岛素抵抗的遗传学:PPAR 途径
- 批准号:
6673568 - 财政年份:2003
- 资助金额:
$ 50.73万 - 项目类别:
Genetics of IR in PCOS: The PPAR Pathway
PCOS 中 IR 的遗传学:PPAR 通路
- 批准号:
6786047 - 财政年份:2003
- 资助金额:
$ 50.73万 - 项目类别:
RISK OF CHD IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
多囊卵巢综合症女性患冠心病的风险
- 批准号:
6389130 - 财政年份:2000
- 资助金额:
$ 50.73万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 50.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 50.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 50.73万 - 项目类别:
Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 50.73万 - 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 50.73万 - 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
- 批准号:
10589484 - 财政年份:2023
- 资助金额:
$ 50.73万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 50.73万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 50.73万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 50.73万 - 项目类别: